Cargando…
TGF-β-induced alternative splicing of TAK1 promotes EMT and drug resistance
Transforming growth factor-β (TGF-β) is major inducer of epithelial to mesenchymal transition (EMT), which associates with cancer cell metastasis and resistance to chemotherapy and targeted drugs, through both transcriptional and non-transcriptional mechanisms. We previously reported that in cancer...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486402/ https://www.ncbi.nlm.nih.gov/pubmed/30626936 http://dx.doi.org/10.1038/s41388-018-0655-8 |